Medical Research Council & Innovate UK – Bio-medical Catalyst 2017 – Round 2 Late Stage
Competition open now
Register before midday on 31st May 2017
Apply before midday on 7th June 2017
UK businesses can apply for a share of up to £12 million to develop innovative ideas that will help solve healthcare challenges in this bio-medical catalyst funding competition.
The aim of this competition is to develop innovative healthcare technologies and processes that will help provide one or more of the following:
– disease prevention and proactive management of health and chronic conditions
– earlier and better detection and diagnosis of disease, leading to better patient outcomes
– tailored treatments that either change the underlying disease or offer potential cures
This bio-medical catalyst competition is for late stage awards only. It is seeking projects that test a well-developed concept and show effectiveness in a relevant environment.
For industrial research, you could get:
– up to 70% of your eligible project costs if you are a micro or small business
– up to 60% if you are a medium-sized business
For experimental development projects that are nearer to market, you could get:
– up to 45% of your eligible project costs if you are a micro or small business
– up to 35% if you are a medium-sized business
Project requirements
Projects are expected to range in size from total project costs of £250,000 to £4 million. Projects should last from 12 to 36 months. Projects must start by 1 February 2018 and end by 1 February 2021. An SME must lead the project and it must be carried out in the UK.
Biomedical Catalyst awards fund innovative solutions to healthcare challenges. The aim of the late stage award is to test a well-developed concept and show its effectiveness in a relevant environment. It could do this through:
– initial human proof-of-concept studies
– demonstration of clinical utility and effectiveness
– demonstration of safety and efficacy (including phase I and II clinical trials)
– developing production mechanisms
– prototyping
– market testing
– intellectual property protection
These solutions should be innovative healthcare technologies, products or processes that will help provide one or more of the following:
– disease prevention and proactive management of health and chronic conditions
– earlier and better detection and diagnosis of disease, leading to better patient outcomes
– treatments that either change underlying disease or offer potential cures
Projects from any sector or discipline will be supported, including but not limited to:
– stratified healthcare (both therapy and diagnostic components)
– advanced therapies (cell and gene therapy)
– diagnostics
– digital health
– enabling medical technologies and devices